By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Recro Gainesville LLC v. Actavis Laboratories FL, Inc., Civil Action No. 14-1118-GMS (D.Del. February 24, 2017)(consolidated), the Court,
Continue Reading Judge Sleet Finds that Actavis’ Proposed ANDA Products Infringe Recro’s Asserted Patents

By Memorandum Opinion entered by The Honorable Sue L. Robinson in Merck Sharp & Dohme Corp. v. Teva Pharmaceuticals USA, Inc., Civil Action No. 14-874-SLR (D.Del., November 16, 2016),
Continue Reading After Two Day Bench Trial in ANDA Action, Judge Robinson Finds The ‘353 Patent Valid But Not Infringed by Generic

By Trial Opinion entered by The Honorable Richard G. Andrews, following a bench trial, in Endo Pharmaceuticals Inc. et al. v. Amneal Pharmaceuticals, LLC et al., Civil Action No.
Continue Reading Judge Andrews Concludes that Defendants Failed to Prove Affirmative Defenses of Obviousness and Implied License in ANDA Action

By Memorandum Opinion entered by The Honorable Leonard P. Stark in Novartis AG, et al. v. Ezra Ventures, LLC, Civil Action No. 15-150-LPS (D.Del. September 22, 2016), the Court
Continue Reading Chief Judge Stark Denies Defendants’ Motion for Judgment on Pleadings Seeking to Have Patent-in-Suit Ruled Invalid or Terminally Disclaimed

By Memorandum Order entered by Chief Judge Leonard P. Stark in Cosmo Technologies Ltd. et al. v. Actavis Laboratories FL, Inc., Civil Action No. 15-164-LPS (D.Del. September 2, 2016)
Continue Reading Judge Stark Grants Defendants’ Rogatory Motion Seeking Deposition in Italy of Named Inventor of Patents-In-Suit in Hatch-Waxman Action

By Memorandum Opinion entered by The Honorable Richard G. Andrews in Novartis Pharmaceuticals Corp., et al. v. Zydus Noveltech Inc., Civil Action No. 14-1104-RGA (D.Del., August 7, 2015), the
Continue Reading Judge Andrews Grants Defendant’s Motion to Dismiss Hatch-Waxman Patent Infringement Action Based on Lack of Personal Jurisdiction